Mutual of America Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Sell
39,693
-1,786
-4% -$857K 0.19% 79
2026
Q1
$20.4M Sell
41,479
-385
-0.9% -$209K 0.23% 57
2025
Q4
$24.3M Sell
41,864
-590
-1% -$334K 0.26% 50
2025
Q3
$20.6M Sell
42,454
-2,364
-5% -$1.1M 0.22% 63
2025
Q2
$18.2M Sell
44,818
-1,191
-3% -$498K 0.2% 71
2025
Q1
$22.9M Sell
46,009
-1,339
-3% -$725K 0.26% 45
2024
Q4
$24.6M Sell
47,348
-804
-2% -$442K 0.26% 40
2024
Q3
$29.8M Buy
48,152
+69
+0.1% +$40.8K 0.31% 34
2024
Q2
$26.6M Sell
48,083
-2,520
-5% -$1.44M 0.29% 37
2024
Q1
$29.4M Sell
50,603
-1,045
-2% -$586K 0.32% 37
2023
Q4
$27.4M Sell
51,648
-2,309
-4% -$1.12M 0.32% 38
2023
Q3
$27.3M Sell
53,957
-1,478
-3% -$788K 0.34% 33
2023
Q2
$28.9M Sell
55,435
-629
-1% -$339K 0.33% 36
2023
Q1
$32.3M Buy
56,064
+95
+0.2% +$53.5K 0.38% 30
2022
Q4
$30.8M Buy
55,969
+1,775
+3% +$941K 0.38% 29
2022
Q3
$27.5M Buy
54,194
+863
+2% +$483K 0.37% 30
2022
Q2
$29M Buy
53,331
+790
+2% +$435K 0.37% 33
2022
Q1
$31M Buy
52,541
+556
+1% +$319K 0.33% 32
2021
Q4
$34.7M Buy
51,985
+407
+0.8% +$254K 0.35% 28
2021
Q3
$29.5M Buy
51,578
+346
+0.7% +$190K 0.29% 38
2021
Q2
$25.8M Buy
51,232
+383
+0.8% +$181K 0.26% 49
2021
Q1
$23.2M Buy
50,849
+993
+2% +$474K 0.24% 52
2020
Q4
$23.2M Sell
49,856
-1,479
-3% -$693K 0.26% 49
2020
Q3
$22.7M Sell
51,335
-2,260
-4% -$934K 0.3% 43
2020
Q2
$19.4M Sell
53,595
-1,069
-2% -$358K 0.27% 47
2020
Q1
$15.5M Buy
54,664
+640
+1% +$202K 0.26% 57
2019
Q4
$17.6M Buy
54,024
+307
+0.6% +$93.1K 0.22% 61
2019
Q3
$15.6M Buy
53,717
+424
+0.8% +$121K 0.22% 65
2019
Q2
$15.7M Sell
53,293
-430
-0.8% -$118K 0.22% 64
2019
Q1
$14.7M Buy
53,723
+845
+2% +$210K 0.21% 68
2018
Q4
$11.8M Buy
52,878
+854
+2% +$200K 0.2% 75
2018
Q3
$12.7M Buy
52,024
+130
+0.3% +$29.9K 0.18% 86
2018
Q2
$10.7M Buy
51,894
+506
+1% +$107K 0.16% 104
2018
Q1
$10.6M Buy
51,388
+687
+1% +$144K 0.16% 100
2017
Q4
$9.63M Buy
50,701
+1,929
+4% +$370K 0.15% 126
2017
Q3
$9.23M Buy
48,772
+1,044
+2% +$189K 0.15% 116
2017
Q2
$8.33M Buy
47,728
+977
+2% +$164K 0.14% 122
2017
Q1
$7.18M Buy
46,751
+92
+0.2% +$14.1K 0.13% 166
2016
Q4
$6.58M Buy
46,659
+588
+1% +$86.7K 0.12% 182
2016
Q3
$7.33M Buy
46,071
+251
+0.5% +$38.7K 0.15% 133
2016
Q2
$6.77M Buy
45,820
+667
+1% +$98.4K 0.14% 134
2016
Q1
$6.39M Buy
45,153
+600
+1% +$80.4K 0.14% 148
2015
Q4
$6.32M Buy
44,553
+285
+0.6% +$38K 0.14% 144
2015
Q3
$5.41M Buy
44,268
+580
+1% +$75.6K 0.13% 160
2015
Q2
$5.67M Buy
43,688
+59
+0.1% +$7.69K 0.12% 168
2015
Q1
$5.86M Buy
43,629
+441
+1% +$56.9K 0.13% 171
2014
Q4
$5.41M Buy
43,188
+227
+0.5% +$27.6K 0.12% 191
2014
Q3
$5.23M Buy
42,961
+898
+2% +$109K 0.12% 176
2014
Q2
$4.96M Sell
42,063
-489
-1% -$57.6K 0.12% 195
2014
Q1
$5.12M Buy
42,552
+4,896
+13% +$582K 0.12% 185
2013
Q4
$4.19M Buy
37,656
+416
+1% +$41.4K 0.1% 260
2013
Q3
$3.43M Buy
37,240
+560
+2% +$50.6K 0.09% 292
2013
Q2
$3.1M Buy
+36,680
New +$3.05M 0.09% 306

Other funds holding TMO

Mutual of America Capital Management's TMO Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, selling an estimated $857K and leaving 39,693 shares worth $19.9M. The position accounts for 0.19% of the portfolio, ranked #79.

Mutual of America Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.7M in Q4 2021. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mutual of America Capital Management held 39,693 shares of Thermo Fisher Scientific worth $19.9M as of Q2 2026.
  • Mutual of America Capital Management sold 1,786 Thermo Fisher Scientific shares in Q2 2026, an estimated $857K.
  • Thermo Fisher Scientific made up 0.19% of Mutual of America Capital Management's portfolio in Q2 2026, its #79 holding.
  • Mutual of America Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's Thermo Fisher Scientific position peaked at $34.7M in Q4 2021.
  • 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.